• Latest Posts
In Depth 7 Sep 2023

Hope for patients with life-threatening muscle disorder after years of clinical trial failures

Santhera and ReveraGen announce first patient with Becker muscular dystrophy dosed in FDA-funded pilot study

Sarepta looks for quick approval for Duchenne muscular dystrophy gene therapy treatment

Eight diseases CRISPR technology could cure

CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M

Muscular Dystrophy Drug Fails in Phase 2 Trial

ADVERTISEMENT

This Small Molecule Protects the Muscles of Patients With Duchenne Muscular Dystrophy

Cutting Through the BS in Biopharma: How To Spot Hype

Swiss Scientists Have Designed New Proteins to Treat Muscular Dystrophy

French Nonprofit Partners with Big American Name to Advance a Gene Therapy for Muscular Dystrophy

More News! 30 May 2017

FDA Fast Tracks Muscular Dystrophy Drug backed by Woodford

Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?

ADVERTISEMENT